New clinical application prospects of artemisinin and its derivatives: a scoping review
Abstract Background Recent research has suggested that artemisinin and its derivatives may have therapeutic effects on parasites, viruses, tumors, inflammation and skin diseases. This study aimed to review clinical research on artemisinin and its derivatives except anti-malaria and explore possible...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-12-01
|
| Series: | Infectious Diseases of Poverty |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40249-023-01152-6 |
| _version_ | 1797272824552882176 |
|---|---|
| author | Yangmu Huang Yang Yang Guangqi Liu Ming Xu |
| author_facet | Yangmu Huang Yang Yang Guangqi Liu Ming Xu |
| author_sort | Yangmu Huang |
| collection | DOAJ |
| description | Abstract Background Recent research has suggested that artemisinin and its derivatives may have therapeutic effects on parasites, viruses, tumors, inflammation and skin diseases. This study aimed to review clinical research on artemisinin and its derivatives except anti-malaria and explore possible priority areas for future development. Methods Relevant articles in English and Chinese published before 28 October 2021 were reviewed. All articles were retrieved and obtained from databases including WanFang, PubMed/MEDLINE, the Cochrane Library, China National Knowledge International, Embase, OpenGrey, the Grey Literature Report, Grey Horizon, and ClinicalTrials.gov. Studies were selected for final inclusion based on predefined criteria. Information was then extracted and analyzed by region, disease, outcome, and time to identify relevant knowledge gaps. Results Seventy-seven studies on anti-parasitic (35), anti-tumor (16), anti-inflammatory (12), anti-viral (8), and dermatological treatments (7) focused on the safety and efficacy of artemisinin and its derivatives. The anti-parasitic clinical research developed rapidly, with a large number of trials, rapid clinical progress, and multiple research topics. In contrast, anti-viral research was limited and mainly stayed in phase I clinical trials (37.50%). Most of the studies were conducted in Asia (60%), followed by Africa (27%), Europe (8%), and the Americas (5%). Anti-parasite and anti-inflammatory research were mainly distributed in less developed continents such as Asia and Africa, while cutting-edge research such as anti-tumor has attracted more attention in Europe and the United States. At the safety level, 58 articles mentioned the adverse reactions of artemisinin and its derivatives, with only one study showing a Grade 3 adverse event, while the other studies did not show any related adverse reactions or required discontinuation. Most studies have discovered therapeutic effects of artemisinin or its derivatives on anti-parasitic (27), anti-tumor (9), anti-inflammatory (9) and dermatological treatment (6). However, the efficacy of artemisinin-based combination therapies (ACTs) for parasitic diseases (non-malaria) is still controversial. Conclusions Recent clinical studies suggest that artemisinin and its derivatives may be safe and effective candidates for anti-tumor, anti-parasitic, anti-inflammatory and dermatological drugs. More phase II/III clinical trials of artemisinin and its derivatives on antiviral effects are needed. Graphical Abstract |
| first_indexed | 2024-03-07T14:34:40Z |
| format | Article |
| id | doaj.art-658aa1becf414197ac97e38635df6e61 |
| institution | Directory Open Access Journal |
| issn | 2049-9957 |
| language | English |
| last_indexed | 2024-03-07T14:34:40Z |
| publishDate | 2023-12-01 |
| publisher | BMC |
| record_format | Article |
| series | Infectious Diseases of Poverty |
| spelling | doaj.art-658aa1becf414197ac97e38635df6e612024-03-05T20:43:05ZengBMCInfectious Diseases of Poverty2049-99572023-12-0112111210.1186/s40249-023-01152-6New clinical application prospects of artemisinin and its derivatives: a scoping reviewYangmu Huang0Yang Yang1Guangqi Liu2Ming Xu3School of Public Health, Peking UniversitySchool of Public Health, Peking UniversityEnergy Saving and Environmental Protection and Occupational Safety and Health Research Institute, China Academy of Railway Sciences Co., LtdSchool of Public Health, Peking UniversityAbstract Background Recent research has suggested that artemisinin and its derivatives may have therapeutic effects on parasites, viruses, tumors, inflammation and skin diseases. This study aimed to review clinical research on artemisinin and its derivatives except anti-malaria and explore possible priority areas for future development. Methods Relevant articles in English and Chinese published before 28 October 2021 were reviewed. All articles were retrieved and obtained from databases including WanFang, PubMed/MEDLINE, the Cochrane Library, China National Knowledge International, Embase, OpenGrey, the Grey Literature Report, Grey Horizon, and ClinicalTrials.gov. Studies were selected for final inclusion based on predefined criteria. Information was then extracted and analyzed by region, disease, outcome, and time to identify relevant knowledge gaps. Results Seventy-seven studies on anti-parasitic (35), anti-tumor (16), anti-inflammatory (12), anti-viral (8), and dermatological treatments (7) focused on the safety and efficacy of artemisinin and its derivatives. The anti-parasitic clinical research developed rapidly, with a large number of trials, rapid clinical progress, and multiple research topics. In contrast, anti-viral research was limited and mainly stayed in phase I clinical trials (37.50%). Most of the studies were conducted in Asia (60%), followed by Africa (27%), Europe (8%), and the Americas (5%). Anti-parasite and anti-inflammatory research were mainly distributed in less developed continents such as Asia and Africa, while cutting-edge research such as anti-tumor has attracted more attention in Europe and the United States. At the safety level, 58 articles mentioned the adverse reactions of artemisinin and its derivatives, with only one study showing a Grade 3 adverse event, while the other studies did not show any related adverse reactions or required discontinuation. Most studies have discovered therapeutic effects of artemisinin or its derivatives on anti-parasitic (27), anti-tumor (9), anti-inflammatory (9) and dermatological treatment (6). However, the efficacy of artemisinin-based combination therapies (ACTs) for parasitic diseases (non-malaria) is still controversial. Conclusions Recent clinical studies suggest that artemisinin and its derivatives may be safe and effective candidates for anti-tumor, anti-parasitic, anti-inflammatory and dermatological drugs. More phase II/III clinical trials of artemisinin and its derivatives on antiviral effects are needed. Graphical Abstracthttps://doi.org/10.1186/s40249-023-01152-6ArtemisininDerivativesMedicinal effectClinical applicationClinical studyScoping review |
| spellingShingle | Yangmu Huang Yang Yang Guangqi Liu Ming Xu New clinical application prospects of artemisinin and its derivatives: a scoping review Infectious Diseases of Poverty Artemisinin Derivatives Medicinal effect Clinical application Clinical study Scoping review |
| title | New clinical application prospects of artemisinin and its derivatives: a scoping review |
| title_full | New clinical application prospects of artemisinin and its derivatives: a scoping review |
| title_fullStr | New clinical application prospects of artemisinin and its derivatives: a scoping review |
| title_full_unstemmed | New clinical application prospects of artemisinin and its derivatives: a scoping review |
| title_short | New clinical application prospects of artemisinin and its derivatives: a scoping review |
| title_sort | new clinical application prospects of artemisinin and its derivatives a scoping review |
| topic | Artemisinin Derivatives Medicinal effect Clinical application Clinical study Scoping review |
| url | https://doi.org/10.1186/s40249-023-01152-6 |
| work_keys_str_mv | AT yangmuhuang newclinicalapplicationprospectsofartemisininanditsderivativesascopingreview AT yangyang newclinicalapplicationprospectsofartemisininanditsderivativesascopingreview AT guangqiliu newclinicalapplicationprospectsofartemisininanditsderivativesascopingreview AT mingxu newclinicalapplicationprospectsofartemisininanditsderivativesascopingreview |